SCHEMBL2298900

SCHEMBL2298900

CC(C)c1nc2c(c(C3=CCCC3)c1C(=O)O)C(=O)CC(C)(C)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
ALDH1A1 P00352 8/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 2/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP3A4 P08684 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HTT P42858 2/20 0.32
CETP P11597 1/20 0.31
NPSR1 Q6W5P4 2/20 0.31
HCAR3 P49019 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31
FABP3 P05413 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL663765 0.80 CETP (0.47) CETP
SCHEMBL16363097 0.76 CYP1A2 (0.34) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL16363069 0.74 ALDH1A1 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL663938 0.74 CETP (0.36) CETP
SCHEMBL2298907 0.72 CYP1A2 (0.35) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL15182457 0.70 PTGES (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL15182479 0.69 PTGES (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL15182456 0.69 LMNA (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL10196403 0.68 CETP (0.43) CYP1A2CYP2C9CYP2C19GAALMNA
SCHEMBL663282 0.66 CETP (0.42) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536733-A1 TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION Boehringer Ingelheim International GmbH (DE) 2012-12-26 EP disclosed
WO-2011101424-A1 TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-25 WO disclosed